Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRRUS: Rimonabant and Nicotine Patch for Smoking Cessation
NCT00458718Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rimonabant in Tobacco Use Disorder (TUD), sponsored by Sanofi. Started Sep 2004; status: completed.
02
Drugs
rimonabant
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00458718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458718.